Scienture Holdings Inc (SCNX)

Currency in USD
0.360
-0.018(-4.76%)
Closed·
0.375+0.014(+3.94%)
·
SCNX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.3490.398
52 wk Range
0.2382.600
Key Statistics
Prev. Close
0.378
Open
0.393
Day's Range
0.349-0.398
52 wk Range
0.238-2.6
Volume
493.37K
Average Volume (3m)
569.8K
1-Year Change
-65.6857%
Book Value / Share
1.64
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SCNX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.500
Upside
+316.67%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year

Scienture Holdings Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 1.500
(+316.67% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Maxim Group
Buy1.50+316.67%-New Coverage24/02/2026

Earnings

Latest Release
18/05/2026
EPS / Forecast
-0.08 / --
Revenue / Forecast
56.33K / --
EPS Revisions
Last 90 days

Compare SCNX to Peers and Sector

Metrics to compare
SCNX
Peers
Sector
Relationship
P/E Ratio
−0.3x−0.5x−0.5x
PEG Ratio
−0.01−0.020.00
Price/Book
0.2x0.8x2.6x
Price / LTM Sales
30.6x0.6x3.0x
Upside (Analyst Target)
316.7%66.3%58.6%
Fair Value Upside
Unlock37.4%10.2%Unlock

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Employees
7

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
969.88K2.39%366.52K
Other Institutional Investors
2.90M7.14%1.10M
Public Companies & Retail Investors
36.76M90.47%13.89M
Total
40.63M100.00%15.35M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
L1 Capital Global Opportunities Master Fund, Ltd.2.65%1,075,000406
L1 Global Manager Pty Ltd2.65%1,075,000406

People Also Watch

1.440
VNRX
+4.35%
0.27
DEVS
+3.85%
0.83
GMEX
+5.07%
1.0900
ONCO
+6.86%

FAQ

What Is the Scienture Holdings (NASDAQ: SCNX) Share Price Today?

The Scienture Holdings stock price today is 0.360 USD.

What Stock Exchange Does Scienture Holdings (SCNX) Trade On?

Scienture Holdings is listed and trades on the Nasdaq Stock Exchange.

What Is the Ticker (Stock Symbol) for Scienture Holdings?

The stock symbol (also called a 'ticker') for Scienture Holdings is "SCNX."

What Is the Current Scienture Holdings Market Capitalisation?

As of today, Scienture Holdings (NASDAQ: SCNX) market cap is 14.990M USD.

What Is Scienture Holdings's (SCNX) Earnings Per Share (TTM)?

The Scienture Holdings EPS is currently -1.808 (Trailing Twelve Months).

When Is the Next Scienture Holdings Earnings Date?

Scienture Holdings's next earnings report will be released on 17/08/2026.

Is SCNX a Buy or Sell From a Technical Analyst Perspective?

Based on today's Scienture Holdings moving averages and other technical indicators, the daily buy/sell signal for SCNX stock is Strong Sell.

How Many Times Has Scienture Holdings Stock Split?

Scienture Holdings has split 4 times. (See the SCNX stock split history page for full effective split date and price information.)

How Many Employees Does Scienture Holdings Have?

Scienture Holdings has 7 employees, based on their latest Companies House report.

What is the current trading status of Scienture Holdings (NASDAQ: SCNX)?

As of 16/06/2026, Scienture Holdings (SCNX) is trading at a share price of 0.360 USD, with a previous close of 0.378 USD. The stock has fluctuated within a day range of 0.349 USD to 0.398 USD, while its 52-week range spans from 0.238 USD to 2.600 USD.

What Is Scienture Holdings (SCNX) Price Target According to Analysts?

The average 12-month price target for Scienture Holdings is 1.500 USD, with a high estimate of 1.5 USD and a low estimate of 1.5 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +316.67% Upside potential.

What Is the SCNX Premarket Price?

SCNX's last pre-market stock price is 0.400 USD. The pre-market share volume is 17,100.000, and the stock has decreased by 0.022, or 5.820%.

What Is the SCNX After Hours Price?

SCNX's last after hours stock price is 0.375 USD, the stock has decreased by 0.014, or 3.940%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.